Parkinson's Disease as a Multiscale Dopaminergic-Ionic-Bioenergetic Disorder

Parkinson's disease (PD) is diagnosed clinically by a characteristic parkinsonian syndrome, while its biology encompasses a heterogeneous set of molecular and cellular processes that converge on progressive dysfunction and loss of vulnerable neuronal populations, particularly dopaminergic neurons of the substantia nigra pars compacta (SNc). The canonical sequence - nigrostriatal degeneration followed by striatal dopamine deficiency - explains major motor manifestations, but it does not fully account for selective neuronal vulnerability or for the possibility that declining dopaminergic signaling may itself reshape the electrophysiological and energetic environment of surviving neurons. This theoretical-translational study proposes a multiscale model in which dopamine loss is treated not as a single primary cause of PD but as one component of a bidirectional feedback architecture linking membrane excitability, Ca²⁺, Na⁺ and K⁺ homeostasis, ATP-dependent ion pumping, mitochondrial redox state, cytosolic dopamine chemistry, α-synuclein, and lysosomal function. A critical distinction is introduced between extracellular/vesicular dopamine signaling, which falls as nigrostriatal terminals fail, and cytosolic dopamine, which may become oxidatively toxic when vesicular sequestration and organellar homeostasis are impaired. The framework predicts that reduced dopaminergic autoinhibition in defined SNc subpopulations can modify firing and Ca²⁺ entry; CaV1 currents can increase mitochondrial workload, whereas CaV2.3 and T-type currents can reshape somatodendritic Ca²⁺ burden and excitability; Na⁺ entry and impaired α3-Na⁺/K⁺-ATPase activity can raise energetic demand and membrane depolarization; K⁺ conductances, including SK and KATP channels, can switch between compensatory and maladaptive roles depending on metabolic state; and ATP depletion can weaken Na⁺/K⁺-ATPase, PMCA and SERCA function, thereby converting energetic stress into further ionic stress. Mitochondrial Ca²⁺ overload, impaired NCLX-mediated Ca²⁺ extrusion, complex-I dysfunction, dopamine oxidation and α-synuclein-dependent membrane/lysosomal disturbances are incorporated as amplifying modules. The resulting system is formalized by coupled differential equations for membrane voltage, intracellular Na⁺, K⁺ and Ca²⁺, mitochondrial Ca²⁺, ATP, reactive oxygen species, dopamine pools and α-synuclein burden. The central falsifiable proposition is that loss of dopaminergic signaling, under a restricted set of cellular states, can amplify rather than merely report neurodegeneration by shifting surviving neurons toward an ionically and bioenergetically unstable regime. A staged validation program is proposed using human induced-pluripotent-stem-cell-derived dopaminergic neurons, ex vivo electrophysiology, genetically encoded ion/redox sensors, mitochondrial flux measurements, α-synuclein perturbation, and in vivo models designed to separate dopamine depletion from direct neurotoxin injury. The model is explicitly preclinical and hypothesis-generating; it does not establish that dopamine deficiency independently causes PD, and it is constructed to permit rejection of that claim if ionic and energetic changes fail to follow selective manipulation of dopaminergic signaling.